Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions
NCT05730855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2023-09-13
Summary
The aim of this study is to evaluate salivary expression of lncRNA DQ786243 as a potential marker for diagnosis of oral potentially malignant lesions compared to normal controls and its effect on salivary expression of miRNA146a.
Conditions
- Potentially Malignant Lesions
- Oral Lichen Planus
- Leukoplakia, Oral
Interventions
- DIAGNOSTIC_TEST
-
Real-time Polymerase Chain Reaction technique
Real-time Polymerase Chain Reaction technique
Sponsors & Collaborators
-
Fayoum University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2022-12-24
- Completion
- 2023-01-23
Countries
- Egypt
Study Locations
More Related Trials
-
Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas
NCT03687294 ·Status: UNKNOWN
-
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
NCT06031337 ·Status: COMPLETED
-
The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw
NCT03418454 ·Status: UNKNOWN
-
Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions
NCT04955197 ·Status: UNKNOWN
-
Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
NCT01987934 ·Status: UNKNOWN
-
Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population
NCT06471270 ·Status: COMPLETED ·Phase: NA
-
Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
NCT00507182 ·Status: COMPLETED ·Phase: NA
-
Diagnostic and Prognostic Accuracy of Gold Nanoparticles in Salivary Gland Tumours
NCT04907422 ·Status: COMPLETED
-
Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
NCT01636544 ·Status: COMPLETED ·Phase: NA
-
Dipeptidyl Peptidase-4 Link With Oral Cancer and Premalignant Lesions
NCT06087042 ·Status: COMPLETED
-
Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders
NCT02790853 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions
NCT02323672 ·Status: COMPLETED
-
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
NCT00542373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
NCT06060288 ·Status: UNKNOWN
-
Least Invasive Nonlinear Light Microscopy
NCT00767442 ·Status: UNKNOWN
-
Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression
NCT01531881 ·Status: COMPLETED
-
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
NCT03975322 ·Status: RECRUITING
-
Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment
NCT04622462 ·Status: RECRUITING
-
Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
NCT00154973 ·Status: UNKNOWN
-
Early Diagnosis of Oral Cancer by Detecting p16 Hydroxymethylation
NCT02967120 ·Status: UNKNOWN
-
Diagnostic Aids for Detection and Diagnosis of Oral Cancer
NCT02251639 ·Status: WITHDRAWN ·Phase: PHASE1
-
Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
NCT02401763 ·Status: UNKNOWN
-
Cathelicidin LL-37 Relation to Potentially Malignant Lesions
NCT06219330 ·Status: COMPLETED
-
Detecting Lesions in the Oral Cavity With Thermal Imaging
NCT00868725 ·Status: COMPLETED
-
Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions
NCT06154551 ·Status: COMPLETED